Funding awarded
- Dissecting the contribution of mis-splicing in cancer phenotypes through multi-omic single-cell approaches awarded by National Cancer Institute Principal Investigator 2025 - 2027
- Deciphering the fitness determinants of clonal mosaicism- ELA Stage II awarded by The Mark Foundation for Cancer Research Key Personnel 2025 - 2026
- Charting the differentiation topology of SF3B1 mutated clonal hematopoiesis (CH) and myelodysplastic syndromes (MDS) via a multi-omics single-cell toolkit awarded by National Heart, Lung, & Blood Institute Key Personnel 2022 - 2026
- Expanding the GoT toolkit to link single-cell clonal genotypes with protein, transcriptomic, epigenomic and spatial phenotypes awarded by National Cancer Institute Key Personnel 2022 - 2025
- Deciphering the fitness determinants of clonal mosaicism awarded by The Mark Foundation for Cancer Research Key Personnel 2022 - 2024